KEGG   DRUG: Tegafur, gimeracil and oteracil potassiumHelp
Entry
D06399            Mixture   Drug                                   

Name
Tegafur, gimeracil and oteracil potassium;
Ts-1 (TN);
Teysuno (TN)
Component
Tegafur [DR:D01244], Gimeracil [DR:D01846], Potassium 2,6-dihydroxytriazinecarboxylate [CPD:C15997]
Remark
Therapeutic category: 4229
ATC code: L01BC53
Product: D06399<JP>
Efficacy
Antineoplastic, Antimetabolite
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01B ANTIMETABOLITES
    L01BC Pyrimidine analogues
     L01BC53 Tegafur, combinations
      D06399  Tegafur, gimeracil and oteracil potassium <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   422  Antimetabolites
    4229  Others
     D06399  Tegafur, gimeracil and oteracil potassium
Antineoplastics [br08340.html]
 D06399
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D06399
BRITE hierarchy
Other DBs
PubChem: 47208056
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system